Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel (EDOX-APT): A Prospective Randomized Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Edoxaban (Primary) ; Aspirin; Clopidogrel
- Indications Thromboembolism
- Focus Pharmacodynamics
- Acronyms EDOX-APT
- 25 Oct 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2018.
- 25 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.